| Ms Melissa Ann Rowan, MS-CCC-SLP | |
|
207 N Main St, Ainsworth, NE 69210-1353 | |
| (402) 387-1420 | |
| Not Available |
| Full Name | Ms Melissa Ann Rowan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 207 N Main St, Ainsworth, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114247525 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1333 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Melissa Ann Rowan, MS-CCC-SLP 311 N Thatcher St, Valentine, NE 69201-1765 Ph: (402) 389-7314 | Ms Melissa Ann Rowan, MS-CCC-SLP 207 N Main St, Ainsworth, NE 69210-1353 Ph: (402) 387-1420 |
News Archive
Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.
In an advance that could lead to better identification of malignant pediatric adrenocortical tumors, and ultimately to better treatment, researchers have mapped the "genomic landscape" of these rare childhood tumors. Their genomic mapping has revealed unprecedented details, not only of the aberrant genetic and chromosomal changes that drive the cancer, but the sequence of those changes that trigger it.
ASN President Dr. Joseph V. Bonventre, MD, PhD, spoke at the American Diabetes Association's annual meeting, 71st Scientific Session, this June in San Diego. Dr. Bonventre was featured at a symposium entitled "New Concepts in Diagnosing and Treating Diabetic Nephropathy."
Mylan N.V. today announced the U.S. Federal Trade Commission has cleared the company's proposed transaction to acquire Perrigo Company plc subject to Mylan's divestiture of certain products following the consummation of the offer.
A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center's kidney cancer program. The study, published in the International Journal of Radiation Oncology*Biology*Physics, could offer new hope for patients with a historically dismal condition.
› Verified 6 days ago
Mrs. Kimberly Buckendahl, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Shawnee Latimer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Tylee Schroeder, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Jordan Maurer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Maggie Alderson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Susan Haskell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 |